GlassScriptPhysician profile
Melanie Hoch
NPI 1598181927
$2,827.44
in general payments reported to CMS, 2019-2025
15 companies · $51.72 in 2025
The $51.72 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $891 · 2024: $1,884 · 2025: $51.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,857 · Travel and Lodging: $962 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,856.68 |
| Travel and Lodging | $962.31 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,651.67 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $339.68 | 2023-2024 | |
| Lilly USA, LLC | $117.33 | 2024 | Taltz |
| Amgen INC. | $108.93 | 2023-2024 | Enbrel, Otezla, Amjevita |
| Ucb, INC. | $107.33 | 2023-2024 | Cimzia |
| Novartis Pharmaceuticals Corporation | $96.16 | 2023-2024 | |
| Aurinia Pharma U.S., INC. | $86.21 | 2023 | Lupkynis |
| Pfizer INC. | $68.57 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $63.53 | 2023-2024 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.46 | 2023-2024 | Cyltezo |
| E.R. Squibb & Sons, L.L.C. | $41.77 | 2023 | Orencia |
| Sobi, INC | $36.19 | 2024 | |
| Radius Health, INC. | $22.56 | 2023 | Tymlos |
| Glaxosmithkline, LLC. | $21.26 | 2023 | Benlysta |
| Horizon Therapeutics Plc | $19.79 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Hoch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.